0
0 (0%)
International Stem Cell Corp [ISCO]
Source:
Company Overview
International Stem Cell Corporation is a clinical stage biotechnology company focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities and two revenue-generating businesses offering potential for increased future revenue.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | ( 760 ) 940-6383 |
| Industry | manufacturing |
| CEO | Andrey Semechkin |
| Website | www.internationalstemcell.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $9.1 |
| Operating Profit | $-0.1 |
| Net Income | $-0.2 |
| Net Cash | $-0.4 |
Profit Ratios
| Gross Margin | $5.3 |
| Operating Margin | -0.8 |
| Profit as % of Revenues | -2,545.9% |
| Profit as % of Assets | -4% |
| Profit as % of Stockholder Equity | 5.3% |
Management Effectiveness
| Return on Equity | 5.3% |
| Return on Assets | -4% |
| Turnover Ratio | 172% |
| EBITA | $-0.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $5.2 |
| Total Liabilities | $4.8 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $-0.2 |
| Financing Cash Flow | $-0.2 |
